相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
Viviane Hess et al.
LANCET ONCOLOGY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer
S Ailawadhi et al.
ONCOLOGY (2006)
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
KW Lee et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2005)
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
XG Ni et al.
EJSO (2005)
Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic,gastric cancer:: A Federation Francophone de Cancerologie Digestive Group Study -: FFCD 9803
O Bouche et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer
H Sorbye et al.
ACTA ONCOLOGICA (2004)
Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs
S Ohtsukasa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
